microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

Despite being considered a single disease, Diffuse Large B Cell Lymphoma (DLBCL) presents with variable backgrounds, which results in heterogeneous outcomes among patients, with 40% of them still having primary refractory disease or relapse. Thus, novel biomarkers are needed. In addition, multiple f...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrabeiti-Etxebarria, Ane, Bilbao-Aldaiturriaga, Nerea, Arzuaga-Mendez, Javier, Martin-Arruti, Maialen, Cozzuto, Luca, Gaafar, Ayman, Ruiz-Diaz, Irune, Guerra, Isabel, Martin-Guerrero, Idoia, Lopez-Lopez, Elixabet, Gutierrez-Camino, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374576/
https://www.ncbi.nlm.nih.gov/pubmed/37500691
http://dx.doi.org/10.1038/s41598-023-39271-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374576/
https://www.ncbi.nlm.nih.gov/pubmed/37500691
http://dx.doi.org/10.1038/s41598-023-39271-7

Ejemplares similares